The invention relates to a compound for use in a method of treatment or prevention of migraine and/or symptoms thereof. The compound is selected from beta-hydroxybutyric acid (βHB) or a pharmaceutically acceptable salt thereof, acetoacetate (AcAc) or a pharmaceutically acceptable salt thereof, a metabolic precursor of βHB or AcAc 1,3-butanedio and a compound comprising an acetoacetyl- or 3-hydroxybutyrate moiety. The invention further relates to a pharmaceutical composition comprising βHB, AcAc or a pharmaceutically acceptable salt thereof.
本发明涉及一种用于治疗或预防偏头痛和/或偏头痛症状的化合物。该化合物选自β-羟基
丁酸(βHB)或其药学上可接受的盐、
乙酰乙酸酯(AcAc)或其药学上可接受的盐、βHB或AcAc的代谢前体1,3-
丁二酸和包含乙酰乙酰基或3-羟基
丁酸分子的化合物。本发明还涉及一种药物组合物,其中包含 βHB、AcAc 或其药学上可接受的盐。